EGFR and neoplasm: It was recorded to be involved in the process of angiogenesis which increases the proliferation of tumor cells, invasiveness, and metastasis.17 EGFR inhibitors (e.g. erlotinib)18 are one of the most important FDA-approved drugs for cancer treatment, Fig. 1.